Literature DB >> 33325655

Prognostic significance of the preoperative systemic immune-inflammation index in patients with oral cavity squamous cell carcinoma treated with curative surgery and adjuvant therapy.

Sheng-Ping Hung1, Pei-Rung Chen2, Tsung-Ying Ho3, Kai-Ping Chang4, Wen-Chi Chou5, Ching-Hsin Lee1, Yao-Yu Wu1, Po-Jui Chen1, Chia-Hsin Lin1, Yung-Chih Chou1, Kang-Hsing Fan6, Chien-Yu Lin1, Bing-Shen Huang1,7, Joseph Tung-Chieh Chang1, Chun-Chieh Wang1, Ngan-Ming Tsang1.   

Abstract

OBJECTIVES: To investigate the prognostic value of the preoperative systemic immune-inflammation index (SII) in patients with oral cavity squamous cell carcinoma (OC-SCC) treated with curative surgery followed by adjuvant radiotherapy (RT) or chemoradiotherapy (CCRT).
MATERIALS AND METHODS: We retrospectively reviewed the clinical records of patients with OC-SCC who received surgery and postoperative adjuvant RT/CCRT between January 2005 and December 2012. Blood samples were drawn in the 2 weeks preceding surgery. SII was calculated by multiplying the absolute neutrophil and platelet counts, and then, divided by the absolute lymphocyte count, and its optimal cutoff value was identified using the Youden's index. The study endpoints included overall survival (OS), local control (LC), regional control (RC), and distant control (DC).
RESULTS: The study sample consisted of 993 patients (58.8% of them treated with CCRT). The optimal cutoff value for SII was 810.6. A total of 347 (34.9%) study participants had high preoperative SII values. After allowance for potential confounders in multivariable analysis, high SII values were independently associated with less favorable DC (adjusted hazard ratio [HR] = 1.683, p = 0.001) and OS (adjusted HR = 1.466, p < 0.001). No independent association between SII and LC/RC was observed.
CONCLUSION: Increased SII values predict poor DC and OS in patients with OC-SCC treated with curative resection and adjuvant RT/CCRT. Owing to the higher risk of systemic failure in this patient group, a thorough follow-up surveillance schedule may be advisable pending independent confirmation of our data.
© 2020 The Authors. Cancer Medicine published by John Wiley & Sons Ltd.

Entities:  

Keywords:  oral cavity squamous cell carcinoma; prognosis; radiotherapy/chemoradiotherapy; risk factors; systemic immune-inflammation index

Mesh:

Year:  2020        PMID: 33325655      PMCID: PMC7877364          DOI: 10.1002/cam4.3650

Source DB:  PubMed          Journal:  Cancer Med        ISSN: 2045-7634            Impact factor:   4.452


  33 in total

1.  The failure patterns of oral cavity squamous cell carcinoma after intensity-modulated radiotherapy-the university of iowa experience.

Authors:  Min Yao; Kristi Chang; Gerry F Funk; Heming Lu; Huaming Tan; Judith Wacha; Kenneth J Dornfeld; John M Buatti
Journal:  Int J Radiat Oncol Biol Phys       Date:  2007-02-02       Impact factor: 7.038

2.  Defining risk levels in locally advanced head and neck cancers: a comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (# 9501).

Authors:  Jacques Bernier; Jay S Cooper; T F Pajak; M van Glabbeke; J Bourhis; Arlene Forastiere; Esat Mahmut Ozsahin; John R Jacobs; J Jassem; Kie-Kian Ang; J L Lefèbvre
Journal:  Head Neck       Date:  2005-10       Impact factor: 3.147

3.  Pretreatment lymphocyte-to-monocyte ratio as an independent prognostic factor for head and neck cancer.

Authors:  Satoshi Kano; Akihiro Homma; Hiromitsu Hatakeyama; Takatsugu Mizumachi; Tomohiro Sakashita; Tomohiko Kakizaki; Satoshi Fukuda
Journal:  Head Neck       Date:  2016-09-12       Impact factor: 3.147

4.  Combined radiation therapy and surgery in the management of advanced head and neck cancer: final report of study 73-03 of the Radiation Therapy Oncology Group.

Authors:  S Kramer; R D Gelber; J B Snow; V A Marcial; L D Lowry; L W Davis; R Chandler
Journal:  Head Neck Surg       Date:  1987 Sep-Oct

5.  Postoperative radiotherapy in squamous cell carcinoma of the oral cavity: the importance of the overall treatment time.

Authors:  J A Langendijk; M A de Jong; C R Leemans; R de Bree; L E Smeele; P Doornaert; B J Slotman
Journal:  Int J Radiat Oncol Biol Phys       Date:  2003-11-01       Impact factor: 7.038

6.  When and how should multiple imputation be used for handling missing data in randomised clinical trials - a practical guide with flowcharts.

Authors:  Janus Christian Jakobsen; Christian Gluud; Jørn Wetterslev; Per Winkel
Journal:  BMC Med Res Methodol       Date:  2017-12-06       Impact factor: 4.615

7.  Postoperative radiotherapy with or without concurrent chemotherapy for oral squamous cell carcinoma in patients with three or more minor risk factors: a propensity score matching analysis.

Authors:  Kang-Hsing Fan; Yen-Chao Chen; Chien-Yu Lin; Chung-Jan Kang; Li-Yu Lee; Shiang-Fu Huang; Chun-Ta Liao; Shu-Hang Ng; Hung-Ming Wang; Joseph Tung-Chieh Chang
Journal:  Radiat Oncol       Date:  2017-11-22       Impact factor: 3.481

8.  Systemic immune-inflammation index predicting chemoradiation resistance and poor outcome in patients with stage III non-small cell lung cancer.

Authors:  Yu-Suo Tong; Juan Tan; Xi-Lei Zhou; Ya-Qi Song; Ying-Jian Song
Journal:  J Transl Med       Date:  2017-10-31       Impact factor: 5.531

9.  Preoperative systemic immune-inflammation index predicts prognosis of patients with oral squamous cell carcinoma after curative resection.

Authors:  Pengfei Diao; Yaping Wu; Jin Li; Wei Zhang; Rong Huang; Chen Zhou; Yanling Wang; Jie Cheng
Journal:  J Transl Med       Date:  2018-12-18       Impact factor: 5.531

10.  REporting recommendations for tumour MARKer prognostic studies (REMARK).

Authors:  L M McShane; D G Altman; W Sauerbrei; S E Taube; M Gion; G M Clark
Journal:  Br J Cancer       Date:  2005-08-22       Impact factor: 7.640

View more
  2 in total

1.  The Value of SII in Predicting the Mortality of Patients with Heart Failure.

Authors:  Miao Yuan; Fuxian Ren; Dengfeng Gao
Journal:  Dis Markers       Date:  2022-05-19       Impact factor: 3.464

2.  Construction and validation a nomogram to predict overall survival for colorectal signet ring cell carcinoma.

Authors:  Jian-Dong Diao; Li-Xia Ma; Chun-Jiao Wu; Xian-Hong Liu; Xiao-Yun Su; Hong-Yu Bi; Bo Bao; Hao-Wei Yan; Lei Shi; Yong-Jing Yang
Journal:  Sci Rep       Date:  2021-02-09       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.